Precision medicine shut down Bryce Olson’s cancer. Now the Intel Corp. executive wants to help others with advanced cancer realize this same outcome.
Olson is using crowdfunding to make it happen. Intel is contributing $25,000 to the effort through Consano. Olson hopes to raise $1 million, all of which will go to the OHSU Knight Cancer Institute as it embarks on a precision medicine clinical trial next year.
“Intel opened my eyes to the benefits of genomic sequencing and precision medicine,”…
Precision medicine shut down Bryce Olson’s cancer. Now the Intel Corp. executive wants to help others with advanced cancer realize this same outcome.
Olson is using crowdfunding to make it happen. Intel is contributing $25,000 to the effort through Consano. Olson hopes to raise $1 million, all of which will go to the OHSU Knight Cancer Institute as it embarks on a precision medicine clinical trial next year.
“Intel opened my eyes to the benefits of genomic sequencing and precision medicine,”…